Houston facility
-
Eli Lilly Stock Surges Amid FDA Wins and Manufacturing Expansion
Eli Lilly stock jumps as FDA approvals, major contracts, and strategic U.S. investments reshape its financial landscape, signaling a new era for the pharma giant.
Eli Lilly stock jumps as FDA approvals, major contracts, and strategic U.S. investments reshape its financial landscape, signaling a new era for the pharma giant.